Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...

Reagent kits can make the transfection process reliable, scalable, cost-effective and standardized — key considerations for viral vector manufacturing. “Without a partner with a deep ...

Responsible for leadership of viral vector process development and research into new viral vector manufacturing platforms for MassBiologics’ Vector Manufacturing Center. Simultaneous management of ...

Looking forward, greater use of column chromatography technologies in vector manufacturing could facilitate the adoption of ...

the 2nd Viral Vector Process Development & Manufacturing Summit is your must-attend meeting in 2024. Secure your place and get your burning questions answered to enhance process intensification ...

PCI Biotech (OSE: PCIB), today announces its preliminary full year 2024 results. Please find enclosed the interim report and ...

The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected ...

The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its breakthrough approach, Fuse Vectors aims to be the universal solution for AAV ...

These features make recombinant AAV the vector of choice for viral-based gene targeting strategies in both basic and clinical research settings. As AAV vectors became a popular viral gene delivery ...

Cellevate AB, an innovative biotech company developing next-generation cell culture systems to revolutionize biomanufacturing ...

Enhancing Scale-Up, Increasing Quality, and Reducing Costs for AVs, LVVs, AAVs and More The 3rd Viral Vector Process Development and Manufacturing Summit returns to Boston, uniting industry leaders ...